Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
10355-6 Observation Prid Bone mar Pt Nom Wright Giemsa stain   ACTIVE Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain   NAM DefinitionDescription                   MICRO   10355-6   Wright Giemsa stain     Both       0 Wright Gie Stn Mar           BM; BON; Bone marrow; Gie Stn; GMS; ID; Identity or presence; Infectious Disease; InfectiousDisease; MAR; Marrow (bone); Microbiology; minimal angle of resolution; Minimum angle of resolution; Nominal; Point in time; Random; St; Stains; Stn; UniversalLabOrders; Wright Gie Stn; Wrights 2.78 1.0i                     Release 2.78: COMPONENT: Updated to seperate the component from the method; 0
103550-0 Evaluation note Find Outpatient Pt Doc Physical therapy   ACTIVE Physical therapy Outpatient Evaluation note   ADD DefinitionDescription                   DOC.ONTOLOGY   103550-0   Physical therapy             0 PT OP Eval note       N   Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; OP; Point in time; PT; Random; Visit note 2.77 2.77                       0
103551-8 Note Find Outpatient Pt Doc Brain injury   ACTIVE Brain injury Outpatient Note   ADD DefinitionDescription                   DOC.ONTOLOGY   103551-8   Brain injury             0 Brain injury OP Note       N   DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Random; Ulcer; Visit note 2.77 2.77                       0
103552-6 Annual evaluation note Find {Setting} Pt Doc Psychology   ACTIVE Psychology Annual evaluation note   ADD DefinitionDescription                   DOC.ONTOLOGY   103552-6   Psychology             0 Psych Annual eval note       N   Annual eval note; Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note 2.77 2.77                       0
103553-4 Summary note Find {Setting} Pt Doc Psychology   ACTIVE Psychology Summary note   ADD DefinitionDescription                   DOC.ONTOLOGY   103553-4   Psychology             0 Psych Summary note       N   DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note 2.77 2.77                       0
103554-2 Progress note Find {Setting} Pt Doc Surgical oncology   ACTIVE Surgical oncology Progress note   ADD DefinitionDescription                   DOC.ONTOLOGY   103554-2   Surgical oncology             0 Surg Onc Prog note       N   Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; General surgical oncology; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Surg Onc; Visit note 2.77 2.77                       0
103555-9 Escherichia coli O157:H7 DNA PrThr Wound Pt Ord Probe.amp.tar   ACTIVE Escherichia coli O157:H7 DNA [Presence] in Wound by NAA with probe detection   ADD DefinitionDescription                   MICRO   103555-9   Probe.amp.tar     Both       0 E coli O157H7 DNA Wnd Ql NAA+probe       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E coli O157; E coli O157H7; Enterohemorrhagic E. coli; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Wnd 2.77 2.77                       0
103556-7 PLA2G7 & PLAC8 gene expression level Score Bld Pt Qn Molgen   ACTIVE PLA2G7 and PLAC8 gene expression level [Score] in Blood by Molecular genetics method   ADD DefinitionDescription     ratio             MOLPATH   103556-7   Molgen     Both       0 PLA2G7 & PLAC8 gene exp Bld       N   Blood; Levels; Levl; LV; LVL; Molecular genetics; Molecular pathology; MOLPATH; PCR; PLA2G7& PLAC8 gene exp; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; WB; Whole blood 2.77 2.77               {ratio}       0
103557-5 SARS coronavirus 2 Mpro gene mutation detected Prid XXX Pt Nom Molgen   ACTIVE SARS-CoV-2 (COVID-19) Mpro gene mutation detected [Identifier] in Specimen by Molecular genetics method Nominal   ADD DefinitionDescription                   MOLPATH.MUT   103557-5   Molgen     Both       0 SARS-CoV-2 Mpro gene mut Spec       N   2019 Novel Coronavirus; 2019-nCoV; Corona virus; COVID19; COVID-19; Identity or presence; II; Misc; Miscellaneous; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Nominal; Other; PCR; Point in time; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 Mpro gene mut; Severe Acute Respiratory Syndrome; Spec; To be specified in another part of the message; Unspecified; Viral Pneumonias; Wuhan coronavirus 2.77 2.77                       0
103558-3 NR4A3 gene rearrangements Find Bld/Tiss Pt Doc FISH   ACTIVE NR4A3 gene rearrangements in Blood or Tissue by FISH   ADD DefinitionDescription                   MOLPATH.REARRANGE   103558-3   FISH     Both       0 NR4A3 gene Rear Bld/T FISH       N   Blood; CHN; CSMF; Document; Finding; Findings; Fluorescent in situ hybridization; MINOR; Molecular pathology; MOLPATH; MOLPATH.REARRANGEMENTS; NOR1; NR4A3 (9q22.33-q31.1) gene; Nuclear receptor subfamily 4, group A, member 3; Point in time; Random; Rearr; Rearrangement; TEC; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue 2.77 2.77                       0
103559-1 Rhinovirus RNA PrThr Nph Pt Ord Non-probe.amp.tar   ACTIVE Rhinovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection   ADD DefinitionDescription                   MICRO   103559-1   Non-probe.amp.tar     Both       0 Rhinovirus RNA Nph Ql NAA+non-probe       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HRV; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rhino virus; RHV; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification 2.77 2.77                       0
10356-4 Microscopic observation Prid Stool Pt Nom Trichrome stain   DEPRECATED Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain   DEL DefinitionDescription                   MICRO   10356-4   Trichrome stain             0 Deprecated Tri Stn Stl           Bowel movement; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stl; Stn; Stool = Fecal; Tri Stn 2.36 1.0i       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
103560-9 Aldosterone/Renin Ratio Ser/Plas Pt Qn     ACTIVE Aldosterone/Renin [Ratio] in Serum or Plasma   ADD DefinitionDescription     {ratio}             CHEM   103560-9         Both       0 Aldost/Renin SerPl-Rto       N   Angiotensin forming enzyme; Angiotensinogenase; Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.77 2.77               {ratio}       0
103562-5 AB-Fubinaca metabolite 3 MCnc Urine Pt Qn Confirm   ACTIVE AB-Fubinaca metabolite 3 [Mass/volume] in Urine by Confirmatory method   ADD DefinitionDescription     ng/mL             DRUG/TOX   103562-5   Confirm     Both       0 AB-Fubinaca met 3 Ur Cfm-mCnc       N   Ab-fubinaca acid metabolite; AB-Fubinaca met 3; Amb-fubinaca acid metabolite; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; III; LC/MS/MS; Level; Mass concentration; Metab; Metabolites; Metb; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.77 2.77               ng/mL       0
103563-3 Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.19.1 - ^Patient RptPeriod - CMS Assessment   ACTIVE Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.19.1 [CMS Assessment]   PANEL DefinitionDescription                   PANEL.SURVEY.CMS   103563-3   CMS Assessment     Order       0         N   Centers for Medicare and Medicaid Assessment; MDS; MDS - version 3.0 - RAI version 1.19.1; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey 2.79 2.78   Convenience group                   0
103564-1 MDS v3.0 - RAI v1.19.1 - Nursing home comprehensive (NC) item set - ^Patient RptPeriod - CMS Assessment   ACTIVE MDS v3.0 - RAI v1.19.1 - Nursing home comprehensive (NC) item set during assessment period [CMS Assessment]   PANEL DefinitionDescription                   PANEL.SURVEY.CMS   103564-1   CMS Assessment     Order       0         N   Centers for Medicare and Medicaid Assessment; MDS v3.0 - RAI v1.19.1 - NC; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey 2.79 2.78   Panel                   0
103565-8 HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA+Hepatitis E virus RNA PrThr Ser/Plas/Bld^Donor Pt Ord Probe.amp.tar   ACTIVE HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hep C RNA+Hep B DNA+Hep E RNA [Presence] in Serum, Plasma or Blood from Donor by NAA with probe detection   ADD DefinitionDescription                   MICRO   103565-8   Probe.amp.tar     Both       0 HIV1,2+HCV+HEV RNA+HBV DNA S/P/B Dr Napb       N   3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Donr; HBV; HCV; Hep; Hep B; Hep C; Hep E; Hepatis; Hepatit; HepB; HEV; HEV RNA; HIV type 1; HIV type 2; HIV type I; HIV type II; HIV1; HIV1,2+HCV+HBV+HEV; HIV1+HIV2+HCV+HBV; Human immunodeficiency virus; i; II; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; PlasBld; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood 2.77 2.77                       0
103566-6 Metagenomic DNA and RNA Sequencing Prid CSF Pt Nom Sequencing   ACTIVE Metagenomic DNA and RNA Sequencing   ADD DefinitionDescription                   MOLPATH   103566-6   Sequencing     Both       0 MSCSF DNA & RNA       N   Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; high-throughput sequencing; HTS; Identity or presence; Metagenomic DNA & RNA; Molecular pathology; MOLPATH; Next generation sequencing; NGS; Nominal; Point in time; Random; Ribonucleic acid; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.77 2.77                       0
103567-4 Previous cancer therapy Prid ^Patient Pt Nar     ACTIVE Previous cancer therapy (narrative)   NAM DefinitionDescription                   ATTACH.CLINRPT   103567-4         Observation       0 Path report IG       N   ATTACH; ATTACH.CLINRPT; Identity or presence; Narrative; Point in time; Prev; Prev CA Tx; Random; Report 2.78 2.77                     Release 2.78: PROPERTY: This code should not be a doc_ontology and Prid is the appropriate value to attachments. ; 0
103568-2 COVID-19 Vaccine - ^Patient RptPeriod - CMS Assessment   ACTIVE MDS v3.0 - RAI v1.19.1 - COVID-19 Vaccine [CMS Assessment]   ADD DefinitionDescription                   PANEL.SURVEY.CMS   103568-2   CMS Assessment     Subset       0         N   2019 Novel Coronavirus; 2019-nCoV; Centers for Medicare and Medicaid Assessment; Coronavirus disease 2019; COVID19; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Survey 2.77 2.77   Organizer                   0
103569-0 Is the resident's COVID-19 vaccination up to date? Find ^Patient RptPeriod Ord CMS Assessment   ACTIVE MDS v3.0 - RAI v1.19.1 - Is the resident's COVID-19 vaccination up to date? [CMS Assessment]   ADD DefinitionDescription                   SURVEY.CMS   103569-0   CMS Assessment     Observation       0         N   2019 Novel Coronavirus; 2019-nCoV; Centers for Medicare and Medicaid Assessment; Coronavirus disease 2019; COVID19; Finding; Findings; Immunizations; Ordinal; Ql; Qual; Qualitative; Report period; S prime; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; Survey; Vaccine 2.78 2.78                       0
10357-2 Observation Prid Wound Pt Nom Gram stain   ACTIVE Microscopic observation [Identifier] in Wound by Gram stain   NAM DefinitionDescription                   MICRO   10357-2   Gram stain     Both       0 Gram Stn Wnd           Gram Stn; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn; Wnd 2.78 1.0i                     Release 2.78: COMPONENT: Updated to seperate the component from the method; 0
103570-8 AAV serotype rh74 Ab PrThr Ser/Plas Pt Ord IA   ACTIVE AAV serotype rh74 Ab [Presence] in Serum or Plasma by Immunoassay   ADD DefinitionDescription                   MICRO   103570-8   IA     Both       0 AAVrh74 Ab SerPl Ql IA       N   AAVrh74; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS 2.77 2.77                       0
103571-6 Study observation^W fluorescein IV Find Ocular fundus Pt Nom Angiography   ACTIVE Study observation Ocular fundus Angiography W fluorescein IV   ADD DefinitionDescription                   EYE.ANGIO   103571-6   Angiography     Both       0 Stdy obs Ocular fund Angio W fluoresc IV       N   Angio; EYE; EYE.ANGIO; Finding; Findings; Nominal; Point in time; Random; Study report; W fluoresc IV 2.77 2.77                       0
103572-4 Cosmetic product listing - ^FDA package insert - Nar     ACTIVE FDA package insert Cosmetic product listing   MAJ DefinitionDescription                   DOCUMENT.REGULATORY   103572-4         Both       0 FDA insert Cosmetic product listing       N   DOCUMENT.REGULATORY; FDA insert; Narrative; Report; SPL; Structured Product Labelling 2.78 2.77                     Release 2.78: PROPERTY: Removed property not needed for FDA concepts; TIME_ASPCT: Removed Time not needed for FDA concepts; 0
104,672 results found